Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.
about
Pleiotropic effects of statins in the diseases of the liverBacterial infections in cirrhosis: A critical review and practical guidanceImmunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosisLiver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.Markers of bacterial translocation in end-stage liver diseaseGut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemiaImpairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acidsAlbumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysisThe conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosisBeta-blockers in liver cirrhosisLiver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava)Alcoholic liver disease: the gut microbiome and liver cross talkImplication of the intestinal microbiome in complications of cirrhosisThe digestive tract as the origin of systemic inflammationGut Microbiota and Host Reaction in Liver DiseasesNon-invasive diagnosis of hepatitis B virus-related cirrhosisUnderestimation of liver-related mortality in the United States.A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients.New determinants of prognosis in bacterial infections in cirrhosis.Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.Clinical relevance of sarcopenia in patients with cirrhosis.Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?Molecular detection of monocyte chemotactic protein-1 polymorphism in spontaneous bacterial peritonitis patients.Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.Integration of palliative care in end-stage liver disease and liver transplantationHigh mortality of pneumonia in cirrhotic patients with ascites.External validation of bloodstream infection mortality risk score in a population-based cohort.Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.Altered profile of human gut microbiome is associated with cirrhosis and its complications.The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial.Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection.Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia.Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease.Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the LiteraturePostoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.Investigation of Bacteremia due to Aeromonas Species and Comparison with That due to Enterobacteria in Patients with Liver Cirrhosis.
P2860
Q26741176-A389DB1F-D5CE-4C14-9DB5-7763202CDFC9Q26766663-09C14619-D08E-4523-9EAF-39C2F8C8B8EEQ26778064-6F50DC45-5FB0-4379-BAB9-0FE4A21AF841Q26780309-11F45CCE-1F2A-45F9-9004-730F4E913EFCQ26783888-B0D1675F-258C-4D67-8D2C-89F0EE59AAE7Q26826919-6B73B6A9-7E1C-4417-BB4F-7194E797D709Q26864558-BD2E8D00-BD2F-4D01-92A9-28D01AD9693CQ27009006-1FF51A18-84BB-4754-BC9D-F990A40DA696Q27009164-FF719FA9-F86B-4F9B-A8D5-248341AFD0B9Q27012922-3EA8E3C3-BA3A-4C32-B822-D84060C38725Q27024792-F6565887-4973-4AB3-9D70-190DE7ADA830Q27025627-4D8D0F9C-3F49-4F60-80B6-9A173752B408Q28068832-055A7DDE-AE19-46E4-A198-60B25B59157DQ28076873-4CD7C8EF-3337-49F8-9E0E-18B6C4FAA738Q28083295-049DBA6C-FA9F-4E9E-BB92-416A9D0B0870Q30442641-2A5CF42E-69B3-4CCD-8CE4-EEA9E64490BEQ30564165-7B370D24-BA2D-4BC3-8EBE-717566EB76BEQ33638900-2DD321B5-444B-48E2-8858-EB0A39A7869CQ33701184-6ECAC591-030D-4990-B13C-45849082DD40Q33780129-F9902564-BD6E-48D9-929C-51D4EF66FAFCQ33831448-E9635CBD-DEC3-4225-8FC5-2EA082870CE5Q33845474-A12CDC32-0555-4AB6-AB03-F41B4E0EFD86Q33910015-F611E731-138E-40DA-8578-7E977F3B7D7DQ34137375-8B93C773-9A39-4FC5-BB25-BEC0B78D3A9FQ34450128-FAE775A5-8E2A-42D4-ACB8-B103856123CAQ34499979-760C3717-6FD7-4E3D-9949-6595CCA4F71BQ34580244-E407E3C0-4ED0-473B-8366-3D458EAD5B6AQ34626330-A81A1619-97BA-428D-AE42-24E84C4E7BA6Q34708289-38DC5378-C406-420C-96E3-E5D580EABB80Q34861969-6021B5D7-5F87-4B69-A443-A592EE1B2F6AQ35077209-7655CDFE-8345-46D2-894D-5D5C8B69A973Q35170336-6A99CB1A-479D-4CCE-825A-020B7FADBE17Q35177083-2D5354D5-28B2-406C-9F28-533D657EC9F6Q35189328-62F71BE4-8A39-4A9F-AF84-74178DC42D7DQ35221810-9D71CC8A-9836-412A-984B-FB4301DEF534Q35553704-F02EC693-0EE6-43F3-B3A0-C304C6D5F131Q35587116-39189849-8522-4628-A14D-8EBBFCD1D6C5Q35647592-674B8611-50C7-42B3-BFF6-AB78E583D7E5Q35651447-28178951-20D2-481B-A1DF-8CC15DAC9EF8Q35664101-7FFDDF70-75CF-405B-BB35-D57EDB1B1B20
P2860
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Infections in patients with ci ...... used in determining prognosis.
@en
Infections in patients with ci ...... used in determining prognosis.
@nl
type
label
Infections in patients with ci ...... used in determining prognosis.
@en
Infections in patients with ci ...... used in determining prognosis.
@nl
prefLabel
Infections in patients with ci ...... used in determining prognosis.
@en
Infections in patients with ci ...... used in determining prognosis.
@nl
P2093
P1433
P1476
Infections in patients with ci ...... used in determining prognosis.
@en
P2093
Andrew Kenneth Burroughs
Gennaro D'Amico
Giuseppe Fede
Maria Pleguezuelo
Pinelopi Manousou
Vasiliki Arvaniti
P304
1246-56, 1256.e1-5
P356
10.1053/J.GASTRO.2010.06.019
P407
P577
2010-06-14T00:00:00Z